Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 77, Topic 2
In Progress

Assessment and Classification of ICU Sleep Disturbances

Lesson Progress
0% Complete
Assessment and Classification of ICU Sleep Disturbances

Assessment and Classification of ICU Sleep Disturbances

Objective Icon A checkmark inside a circle, symbolizing an achieved goal.

Learning Objective

Apply diagnostic and classification criteria to assess ICU sleep disturbances and guide initial management.

1. Clinical Presentation and Diagnostic Criteria

Accurate evaluation of sleep disturbance severity and etiology in critically ill patients is foundational to targeted interventions. ICU sleep disturbances manifest as fragmented, nonrestorative sleep with downstream effects on cognition and mood. Differentiation from delirium is critical.

A. Sleep Architecture Alterations

  • Predominance of light sleep (N1–N2), with significant loss of deep (N3) and REM sleep.
  • Frequent arousals, reduced overall sleep efficiency, and profound circadian misalignment.

B. Patient‐Reported Symptoms and Clinical Signs

  • Subjective Complaints: Feelings of nonrestorative sleep, delayed sleep onset, daytime fatigue, and mood lability.
  • Neurocognitive Signs: Inattention, disorganized thinking, and a fluctuating level of consciousness, creating a significant overlap with ICU-delirium.
  • Mood Changes: Anxiety, irritability, and transient depressive symptoms are common.

C. Key Precipitants and Risk Factors

The ICU environment itself is a major contributor. Key factors include:

  • Environmental: Constant noise, ambient light, and frequent care-related interruptions.
  • Iatrogenic: Pain, mechanical ventilation, and sedative infusions, which can paradoxically suppress deep and REM sleep.
Pearl Icon A lightbulb, indicating a clinical pearl. Clinical Pearl: Atypical Sleep and Delirium Risk

The absence of normal EEG markers of sleep, such as K-complexes and sleep spindles, despite a patient appearing to be asleep (e.g., based on actigraphy), defines “atypical ICU sleep.” This pattern is strongly correlated with a higher risk of developing delirium.

D. Differentiating Sleep Disruption from Delirium

While both conditions present with altered consciousness and inattention, delirium has distinct criteria and requires dedicated screening. Sleep disturbance is characterized by fragmented sleep and circadian misalignment without primary cognitive disorganization. Delirium, assessed via tools like the CAM-ICU, requires an acute onset, fluctuating course, inattention, and either disorganized thinking or an altered level of consciousness. It is crucial to administer sleep and delirium screening tools concurrently and avoid attributing cognitive changes solely to one or the other.

2. Subjective Assessment Tools

Patient‐reported instruments are vital for capturing the perceived quality of sleep, though their feasibility can be limited in intubated or delirious patients.

A. Richards-Campbell Sleep Questionnaire (RCSQ)

The RCSQ is a five‐item visual analog scale (0–100 mm) where the patient rates their sleep depth, latency, number of awakenings, return to sleep, and overall quality. It is validated in both ventilated and nonventilated ICU patients and shows moderate correlation with polysomnography findings and delirium risk. It should be administered daily, requires minimal training, and is responsive to sleep‐promoting interventions.

Pearl Icon A lightbulb, indicating a clinical pearl. Clinical Pearl: Using RCSQ for Risk Stratification

An RCSQ score below 50 mm is a practical threshold that identifies patients at an elevated risk for delirium. This finding can serve as a trigger to promptly initiate a nonpharmacologic sleep-promoting bundle on the same day.

B. Other Subjective Scales

Tools like the Insomnia Severity Index (ISI) and the Hospital Anxiety and Depression Scale (HADS) were designed for general medical populations and are not formally validated for the acute ICU setting. Their reliance on patient recall and self-report limits their utility in intubated or delirious patients. They are best reserved for use in step-down units or post-ICU settings when communication has improved.

Note Icon An open book, indicating an editor’s note or evidence gap. Editor’s Note: Evidence Gap in Proxy Assessment

A significant evidence gap exists for validated proxy-based sleep assessment scales for noncommunicative ICU patients. While nurse-reported restlessness is often used, it lacks standardization and validation against objective measures. Research into reliable proxy tools is ongoing.

3. Objective Monitoring Modalities

Objective modalities are used to define sleep stages and architecture, but they face significant practical and interpretative challenges in the busy and noisy ICU environment.

A. Polysomnography (PSG)

PSG is the undisputed gold standard for sleep assessment, combining electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), and cardiopulmonary channels. However, its use in the ICU is largely limited to research settings or complex clinical cases (e.g., ruling out severe obstructive sleep apnea) due to equipment complexity, frequent electrode displacement, signal artifact from ICU devices, and the need for expert interpretation.

B. Actigraphy and Bispectral Index (BIS)

  • Actigraphy: This wrist-worn device infers sleep from periods of limb immobility. Its utility is severely confounded by patient paralysis, neuromuscular blockade, or physical restraints.
  • Bispectral Index (BIS): This processed EEG monitor provides a surrogate for sedation depth. It is not designed to be stage-specific for sleep and is highly susceptible to electrical noise and muscle artifact.
Pearl Icon A lightbulb, indicating a clinical pearl. Clinical Pearl: Limitations of Surrogate Monitors

Do not rely on actigraphy or BIS monitoring alone for clinical sleep assessment in the ICU. Both have demonstrated poor correlation with gold-standard PSG and subjective tools like the RCSQ in critically ill patient populations. They should be considered adjuncts at best, not primary diagnostic tools for sleep.

Note Icon An open book, indicating an editor’s note or evidence gap. Editor’s Note: Need for ICU-Adapted Scoring

A major challenge in objective monitoring is the lack of consensus on ICU-specific scoring criteria. Sedative medications alter EEG signatures, and device artifacts degrade signal quality, making standard scoring rules difficult to apply. The development of adapted objective scoring criteria is a critical need for advancing ICU sleep research and clinical care.

4. Classification and Severity Scoring

Standardized metrics help stratify patient risk, guide the urgency of sleep-targeted interventions, and identify important comorbidities like Obstructive Sleep Apnea (OSA).

A. Obstructive Sleep Apnea (OSA) Severity

OSA Severity Based on the Apnea-Hypopnea Index (AHI)
Severity AHI (events/hour) Clinical Implication
Mild 5–15 Consider further diagnostic evaluation post-ICU.
Moderate 15–30 Initiate OSA therapy (e.g., CPAP) if feasible.
Severe > 30 Urgent sleep medicine referral and therapy initiation.

B. ICU Sleep Architecture Patterns (EEG-Based)

EEG-Based Classification of ICU Sleep Patterns
Pattern Features Associated Risk
Normal Clear NREM–REM cycling, preserved spindles/K-complexes. Baseline risk.
Fragmented Frequent arousals, decreased sleep efficiency, loss of deep sleep. Moderate delirium and prolonged ventilation risk.
Atypical Absence of cardinal stage markers (no spindles/K-complexes). Highest delirium and prolonged ventilation risk.

5. Integrated Assessment Framework

A practical approach requires synthesizing subjective reports (RCSQ), delirium screening (CAM-ICU), and, when available, objective data (EEG patterns) to stratify risk and determine the urgency of intervention.

A. Risk Stratification Framework

Integrated Risk Stratification for ICU Sleep Disturbances
Risk Level RCSQ Score (mm) EEG Pattern CAM-ICU Intervention Urgency
Low > 50 Normal Negative Standard care; routine monitoring.
Moderate 25–50 Fragmented Negative / Uncertain Optimize environment and sedation; initiate non-pharmacologic bundle.
High < 25 Atypical Positive Expedite non-pharmacologic bundle + consider targeted pharmacotherapy.

B. Conceptual Algorithm for Initial Management

Daily Assessment
RCSQ + CAM-ICU Screening
Risk Stratification
Combine subjective, cognitive, and objective data
Low Risk
Standard Care
Moderate Risk
Optimize Environment
High Risk
Escalate Interventions
Figure 1: Conceptual Management Algorithm. This flowchart illustrates a tiered approach to ICU sleep management. Daily assessment using tools like the RCSQ and CAM-ICU allows for risk stratification, which then guides the intensity of interventions, from standard environmental controls to escalated non-pharmacologic and pharmacologic therapies.

References

  1. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
  2. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea. J Clin Sleep Med. 2017;13(3):479–504.
  3. Tan X, van Egmond L, Partinen M, Lange T, Benedict C. Interventions for improving sleep and reducing circadian disruption in medical inpatients: a narrative review. Sleep Med. 2019;59:42–50.